STARTING LINZESS
ACCESS COMMUNITY RESOURCES
You are not alone. Get real stories from real people going through everything you are.
Stories from People Like You
“You’re not alone, and you do not have to suffer by yourself.”
Dian, 43,
Prescribed LINZESS for CIC
Don’t Go It Alone
There are millions of people experiencing the same symptoms as you. Each of them at
a different point in their treatment, with lessons learned and advice to give. Get their
real stories and discover online support all right here.
people suffer from IBS-C
(Irritable Bowel Syndrome with
Constipation).*
people suffer from CIC (Chronic
Idiopathic Constipation).*
patients are not satisfied with
over-the-counter treatments alone
and are seeking care with
their doctor.**
*Estimated IBS-C/CIC sufferers within the U.S. through Kantar LINZESS Tracking Study;
Jan–Dec 2020; general population sample only.
**IQVIA Total Patient Tracker – June 2020
*Estimated IBS-C/CIC sufferers within the U.S. through Kantar LINZESS Tracking Study; Jan–Dec 2020; general population sample only.
**IQVIA Total Patient Tracker – June 2020
See Nan’s Story
“Looking back, I realized that I wasted a lot of time, that I probably could have felt better sooner.”
Nan, 54
Prescribed LINZESS for IBS-C
Online Resources
IBSPatient.org
Discover valuable resources, community forums, podcasts, activities, and more all online.
LEARN MORE
PatientsLikeMe.com
An online resource for people who are newly diagnosed or have experiences to share.
LEARN MORE
SIGN UP FOR TIPS & RESOURCES FOR LIVING WITH IBS-C
Get tips, resources, and more information about IBS-C and CIC, plus savings for commercially eligible patients on LINZESS right to your inbox.
NEW TO LINZESS?
We can help you manage your IBS-C or CIC symptoms.
LINZESS is a once-daily pill that’s proven to treat multiple symptoms of IBS-C. It helps you have more frequent and complete bowel movements and helps relieve constipation and overall abdominal symptoms* (belly pain, discomfort, and bloating) associated with IBS-C.
*Abdominal symptoms were studied in combination, not individually.
